[ad_1]
Shares of Kellanova rose 4.6% premarket after the food giant reported better-than-expected second-quarter results and raised its 2024 outlook.
[ad_2]
Source link
FDA approves Eli Lilly’s weight loss drug Zepbound for sleep apnea
An Eli Lilly & Co. Zepbound injection pen arranged in the Brooklyn borough of New York, US, on Thursday, March...